Immunotherapy 2 year limit

Hi everyone, my partner was diagnosed with stage 4 non small cell lung cancer in october 2015, she received chemotherapy initially, which didn't agree with her and after 2 rounds, was sent home for palliative care, she was given 3-4 months. Fortunately we got a second opinion and found a consultant who enrolled her on an early access to medicine scheme for immunotherapy (nivolumab) which she started in March 2016. She received 2 years on this scheme, and from March 2018, she has received her treatment via the cancer drug fund. At a recent consultation we were told that you can only be funded for a maximum of 2 years by the cdf which means that her treatment is due to end in March 2020. This news came as a big shock as my partner has responded to treatment excellently and I have been told by her consultant that her response is in the top 30% in the UK. Not only were we told that her treatment is being stopped, but the worst news of all is that in the future if her disease progresses there is no way she can have nivolumab again, even though it has proven to work for her before. I find this position by nhs England and the cdf absolutely unbelievable, she will basically be denied life saving treatment because she has effectively used up her quota. Since hearing this news I have been trying to find other people in a similar position so we can find a way of getting these life saving drugs prescribed as long as needed, and not as long as budgets permit. I think it is not only unethical but also completely immoral to deny patients medication that is clearly working for them and something must be done to change this. If anyone has any information on how to get continued funding for immunotherapy for patients please send a reply.

Many thanks 

  • Hi does anyone know of successful extension of treatment for immunetherepy beyond the two year limit? 
    Thanks 

  • Thankyou. Anymore info would be greatly appreciated. 

  • Hi Amanda,

    This Tuesday just gone (15 March 2022) I had my 68th infusion of Pembolizumab/Keytruda.

    I've been on this immunotherapy for a shade over four years now. Pretty good going for an initial prognosis of 6 months from a diagnosis of stage 4 NSCLC. Minimal side effects - I've been lucky enough to have years to trial-and-error ways to minimise or offset them.

    By the end of two years I was stable, so theoretically I could have chanced coming off the treatment. On the other hand, "if it ain't broke don't fix it" and I was tolerating it way better than most so my consultant kept things going. Lots of Covid stuff at the time, too, so I'm guessing the "do no harm" option was also the easiest and safest.

    While the primary tumour looks probably reduced to scar tissue (can't really tell without a biopsy) there is a very tiny secondary area that is growing slowly that they haven't quite been able to identify - jury is still out on that one though I'm told radiotherapy (cyberknife?) is an ideal candidate to zap it so I'm not worrying.

    As best I can find out, Merck set the 2 year limit to make the drug look more affordable, and that was the number of doses expected to reach stability anyway. Partly clinical, mostly financial.

    kind regards,
    Steve
     

  • Thankyou so much. Which area do you live. Most information I'm been given is that treatment is for a maximum of 2 years. It's my mum that's on it, been a year now snd she's responding very well. 

  • Thanks so much for your response, so sorry to hear you didn’t achieve additional treatment.  Naive as I am I didn’t think there was going to be any limitations other than how a person responded so a bit of a shock for me.  

    Good luck,  if you have any other info I would appreciate it.

    thanks xx

  • Hi Amanda,

    I live in central London. (I can't say which hospital, that's against the rules here.)

    The NHS here did all the initial scans - everything from brain down to whole body, more than one a day, took the best part of a week all told. I was well impressed. After the verdict came in I claimed on my health insurance for treatment.

    Kind wishes to your Mum. They don't prescribe immuno unless there's a good chance it'll work (they have a test for it) so if she's done a year responding well so far it's pretty certain she'll be able to complete the full 2 year course.

    kind regards
    Steve
     

  • Thankyou. I'm hoping to find a solution for after the two years. Obv subject her coping okay. Have you any idea how much the treatment costs ? Thankyou 

  • Hi Amanda,

    It's horribly, prohibitively, eye-watering expensive. The 200mg dose of Keytruda comes with a list price of £7k. Going private would mean adding on the cost of blood tests, nurses, facilities etc - I've no idea how much they cost. Multiplied by repeating every 3 weeks and it kind of mounts up over time.

    It seems to me that given that only 1 in 5 patients are 50% or more suitable for the drug, and that not all of them are able to tolerate it well enough to do 2 years on it let alone even longer, I'd have thought I'm in a very small very lucky minority. If that's really the case, the two year arbitrary cut-off for NHS strikes me as unfair, to say the least, and not really as cost-effective as NICE pretends.

    kind regards
    Steve
     

  • Yes, I am still doing fine thank you  and good luck to everyone here.

  • Hi Amanda,

    Quick update:

    I checked my statements. A year's private treatment on Pembolizumab every 3 weeks plus blood tests, head+chest scans every 3 months, chinwags with the consultant, etc charged my insurance £109,993.46.

    Not cheap.

    kind regards,
    Steve